These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37151359)

  • 1. Paracetamol toxicity in classic homocystinuria: Effect of
    Elkhateeb N; Hyde S; Hogg SL; Allsop D; Shankar A; Deegan P; Tan CY
    JIMD Rep; 2023 May; 64(3):238-245. PubMed ID: 37151359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine alleviates repression of betaine-homocysteine
    Maclean KN; Jiang H; Phinney WN; Keating AK; Hurt KJ; Stabler SP
    FASEB J; 2019 May; 33(5):6339-6353. PubMed ID: 30768359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria.
    Park I; Bublil EM; Glavin F; Majtan T
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32971905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis.
    Maclean KN; Jiang H; Phinney WN; Mclagan BM; Roede JR; Stabler SP
    Mol Genet Metab; 2021 Feb; 132(2):128-138. PubMed ID: 33483253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies.
    Bublil EM; Majtan T
    Biochimie; 2020 Jun; 173():48-56. PubMed ID: 31857119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of hepatic one-carbon metabolism in classical homocystinuria: Implications of redox-sensitive DHFR repression and tetrahydrofolate depletion for pathogenesis and treatment.
    Maclean KN; Jiang H; Neill PD; Chanin RR; Hurt KJ; Orlicky DJ; Bottiglieri T; Roede JR; Stabler SP
    FASEB J; 2024 Jul; 38(13):e23795. PubMed ID: 38984928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison.
    Sellos-Moura M; Glavin F; Lapidus D; Evans K; Lew CR; Irwin DE
    BMC Health Serv Res; 2020 Mar; 20(1):183. PubMed ID: 32143624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.
    Asamoah A; Wei S; Jackson KE; Hersh JH; Levy H
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocystinuria diagnosis and management: it is not all classical.
    Gerrard A; Dawson C
    J Clin Pathol; 2022 Sep; ():. PubMed ID: 36123115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria?
    Sellos-Moura M; Glavin F; Lapidus D; Evans KA; Palmer L; Irwin DE
    Mol Genet Metab; 2020 May; 130(1):36-40. PubMed ID: 32057642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the gut microbiota dysbiotic in patients with classical homocystinuria?
    Rizowy GM; Poloni S; Colonetti K; Donis KC; Dobbler PT; Leistner-Segal S; Roesch LFW; Schwartz IVD
    Biochimie; 2020 Jun; 173():3-11. PubMed ID: 32105814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract.
    Skvorak K; Mitchell V; Teadt L; Franklin KA; Lee HO; Kruse N; Huitt-Roehl C; Hang J; Du F; Galanie S; Guan S; Aijaz H; Zhang N; Rajkovic G; Kruger WD; Ismaili MHA; Huisman G; McCluskie K; Silverman AP
    Mol Genet Metab; 2023 Aug; 139(4):107653. PubMed ID: 37463544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control.
    Yap S; Naughten E
    J Inherit Metab Dis; 1998 Oct; 21(7):738-47. PubMed ID: 9819703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of pyridoxine-responsive homocystinuria].
    Milosević-Tosić M; Borota J; Katanić D; Vlaski J
    Med Pregl; 1999; 52(11-12):501-4. PubMed ID: 10748775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons Learned from Inherited Metabolic Disorders of Sulfur-Containing Amino Acids Metabolism.
    Kožich V; Stabler S
    J Nutr; 2020 Oct; 150(Suppl 1):2506S-2517S. PubMed ID: 33000152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
    Wilcken DE; Dudman NP; Tyrrell PA
    Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.
    Jiang H; Stabler SP; Allen RH; Maclean KN
    Mol Genet Metab; 2012 Sep; 107(1-2):55-65. PubMed ID: 22633282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.